Ventana VENTANA PD-L1 (SP263) Assay

দেশ: সিঙ্গাপুর

ভাষা: ইংরেজি

সূত্র: HSA (Health Sciences Authority)

থেকে পাওয়া:

Roche Diagnostics Asia Pacific Pte Ltd

শ্রেণী:

Class C IVD

Manufactured by:

Ventana Medical Systems, Inc.

থেরাপিউটিক এলাকা:

Pathology

থেরাপিউটিক ইঙ্গিত:

VENTANA PD-L1 (SP263) Assay is intended for the qualitative detection of the programmed death ligand 1 (PD-L1) protein in formalin-fixed, paraffin-embedded (FFPE) non-small cell lung cancer (NSCLC) tissue stained with OptiView DAB IHC Detection Kit on a BenchMark IHC/ISH instrument. PD-L1 expression in tumor cell (TC) membrane as detected by VENTANA PD-L1 (SP263) Assay in NSCLC is indicated as an aid in identifying patients for treatment with IMFINZI™ (durvalumab), KEYTRUDA® (pembrolizumab) and TECENTRIQ® (atezolizumab). PD-L1 expression in tumor cell (TC) membrane as detected by VENTANA PD-L1 (SP263) Assay in NSCLC may be associated with enhanced survival from OPDIVO® (nivolumab).

পণ্য সারাংশ:

Models: Rabbit Monoclonal Negative Control Ig - 790-4795 / 06683380001, VENTANA PD-L1 (SP263) Assay - 741-7139 / 09484515001

অনুমোদন তারিখ:

2020-12-09